This is a multi-center, international study designed to collect clinical, genetic and quality of life information on females with hemophilia, an inherited bleeding disorder. The study is designed to determine whether there are problems and issues unique to females with hemophilia.
The study involves two questionnaires: one on the diagnosis, symptoms, complications and treatment of each participant to be completed by a staff member; the other is a questionnaire to be completed by the participant on how the disease has affected her life. Finally, for those participants who have not previously had genetic testing, the third part of the study is an optional blood test to determine the genetic cause, what change in the factor VIII or factor IX gene, caused the hemophilia. The test results will be available to those participants who wish to learn their results. With the data we collect we will compile a database to examine the connection between the genetic cause of hemophilia and the course and symptoms of the disease.
Study Type
OBSERVATIONAL
Enrollment
200
Weill Cornell Medical College
New York, New York, United States
Princess Margaret Hospital for Children
Perth, Australia
University Clinic Bonn
Bonn, Germany
University Clinic Munich
The molecular and cytogenetic etiology of the condition will be compiled. Clinical manifestation demonstrated by the female hemophiliacs will be compared to published data available. Genotype and phenotype will be correlated.
Time frame: 1-2 visits
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Munich, Germany
Sheba Medical Center
Tel Litwinsky, Israel
Instituto G. Gaslini
Genova, Italy
A. Bianchi Bonomi Hemophilia Center
Milan, Italy
Nara Medical University
Nara, Japan
University Hospital Utrecht
Utrecht, Netherlands
Malmo University Hospital
Malmo, Sweden
...and 1 more locations